In this study, MO was found to improve Aβ load, synaptic proteins, neurodegeneration, and neuroinflammation which together might explain the amelioration of behavioral, cognitive, learning, and memory impairments in APP/PS1 mice treated with MO. The gene discussed is APP; the disease is memory impairment.